title: Amyloidosis.
authors.affiliation: s.gibbs@ucl.ac.uk
authors.forename: Malvyn
authors.initials: M
authors.lastname: Benjamin
authors.forename: Simon
authors.initials: S
authors.lastname: Gibbs
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001853:Bone Marrow / Q000473:pathology*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003520:Cyclophosphamide / Q000008:administration & dosage; D057210:Delayed Diagnosis; D003907:Dexamethasone / Q000008:administration & dosage; D004417:Dyspnea / Q000209:etiology; D006331:Heart Diseases / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000473:pathology*; D007674:Kidney Diseases / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D033262:Narration; D011719:Pyrazines / Q000008:administration & dosage; D011788:Quality of Life; D000685:Serum Amyloid A Protein / Q000378:metabolism*; D013792:Thalidomide / Q000008:administration & dosage
chemical_list: D015415:Biomarkers; D001897:Boronic Acids; D011719:Pyrazines; D000685:Serum Amyloid A Protein; D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide